Longboard Pharmaceuticals... (LBPH)
NASDAQ: LBPH
· Real-Time Price · USD
59.98
null (null%)
At close: Nov 29, 2024, 7:00 PM
undefined% (1D)
Bid | n/a |
Market Cap | 2.34B |
Revenue (ttm) | 8K |
Net Income (ttm) | -76.34M |
EPS (ttm) | -2.25 |
PE Ratio (ttm) | -26.657777777777778 |
Forward PE | -18.57 |
Analyst | Hold |
Ask | n/a |
Volume | 0 |
Avg. Volume (20D) | 0 |
Open | undefined |
Previous Close | undefined |
Day's Range | 59.98 - 59.98 |
52-Week Range | 59.98 - 59.98 |
Beta | 1.09 |
About LBPH
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LBPH
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LBPH stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts10 months ago
+51.65%
Longboard Pharmaceuticals shares are trading highe...
Unlock content with
Pro Subscription
11 months ago
+13.95%
Longboard Pharmaceuticals shares are trading higher after the company announced it received rare pediatric disease and orphan drug designations from the FDA for bexicaserin (LP352) in Dravet syndrome.